In detail, this association remained significant after adjusting for age, sex, grade, tumor stage, performance status, tumour location, KRAS status, microsatellite instability number of cycles, dose modification and treatment, confirming the importance of *2A e c.2846A>T in predicting toxicity when FOLFOX or FOLFIRI regimens were administered. Here, KRAS is linked to neoplasm.